AAAAAA
Results:
1-14
|
Results: 14
Authors:
LACROIX L
BROERSEN LM
WEINER I
FELDON J
Citation: L. Lacroix et al., THE EFFECTS OF EXCITOTOXIC LESION OF THE MEDIAL PREFRONTAL CORTEX ON LATENT INHIBITION, PREPULSE INHIBITION, FOOD HOARDING, ELEVATED PLUS-MAZE, ACTIVE-AVOIDANCE AND LOCOMOTOR-ACTIVITY IN THE RAT, Neuroscience, 84(2), 1998, pp. 431-442
Authors:
MERGNY JL
LACROIX L
Citation: Jl. Mergny et L. Lacroix, KINETICS AND THERMODYNAMICS OF I-DNA FORMATION - PHOSPHODIESTER VERSUS MODIFIED OLIGODEOXYNUCLEOTIDES, Nucleic acids research, 26(21), 1998, pp. 4797-4803
Authors:
RAHA M
LACROIX L
GLAZER PM
Citation: M. Raha et al., MUTAGENESIS MEDIATED BY TRIPLE HELIX-FORMING OLIGONUCLEOTIDES CONJUGATED TO PSORALEN - EFFECTS OF LINKER ARM LENGTH AND SEQUENCE CONTEXT, Photochemistry and photobiology, 67(3), 1998, pp. 289-294
Authors:
MERGNY JL
PHAN AT
LACROIX L
Citation: Jl. Mergny et al., FOLLOWING G-QUARTET FORMATION BY UV-SPECTROSCOPY, FEBS letters, 435(1), 1998, pp. 74-78
Authors:
WATRIN F
ROECKEL N
LACROIX L
MIGNON C
MATTEI MG
DISTECHE C
MUSCATELLI F
Citation: F. Watrin et al., THE MOUSE NECDIN GENE IS EXPRESSED FROM THE PATERNAL ALLELE ONLY AND LIES IN THE 7C REGION OF THE MOUSE-CHROMOSOME-7, A REGION OF CONSERVEDSYNTENY TO THE HUMAN PRADER-WILLI-SYNDROME REGION, European journal of human genetics, 5(5), 1997, pp. 324-332
Authors:
LACROIX L
Citation: L. Lacroix, DUGUAY,RODOLPHE AND SUZOR-COTE, Liberte, 39(3), 1997, pp. 103-119
Authors:
COHEN S
LACROIX L
BLAKE G
RYBKA W
CAPLAN S
LANEUVILLE P
Citation: S. Cohen et al., HIGH-DOSE ETOPOSIDE AND CYCLOPHOSPHAMIDE THERAPY IN REFRACTORY RELAPSED LYMPHOMAS - AN UPDATE OF 85 PATIENTS/, Blood, 90(10), 1997, pp. 849-849
Authors:
DELAGE R
DESJARDINS L
LACROIX L
LESNERANCE B
NEVILL T
ROY J
LEBLOND PF
DEMERS C
LYONNAIS J
PETITCLERC C
HEWITT A
BERG R
CANTIN G
Citation: R. Delage et al., AUTOLOGOUS BLOOD STEM-CELL TRANSPLANTATION AS INITIAL THERAPY IN PATIENTS WITH POOR-PROGNOSIS NON-HODGKINS-LYMPHOMA, Blood, 88(10), 1996, pp. 468-468
Authors:
LACROIX L
MERGNY JL
LEROY JL
HELENE C
Citation: L. Lacroix et al., INABILITY OF RNA TO FORM THE I-MOTIF - IMPLICATIONS FOR TRIPLEX FORMATION, Biochemistry, 35(26), 1996, pp. 8715-8722
Authors:
CANTIN G
LESPERANCE B
YELLE L
BELANGER D
CANTIN G
BERGERON M
DESJARDINS L
OUELLET P
DUFRESNE J
BEAUREGARD P
LEPINE M
LACROIX L
COUTURE F
GYGER M
Citation: G. Cantin et al., A PHASE-II, OPEN-LABEL STUDY TO EVALUATE 2 DIFFERENT SCHEDULES FOR INTEGRATING FILGRASTIM (RECOMBINANT-METHIONYL HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR) AS ADJUVANT THERAPY IN THE TREATMENT OF PATIENTS WITH HODGKINS LYMPHOMA RECEIVING MOPP ABV HYBRID CHEMOTHERAPY/, Blood, 86(10), 1995, pp. 197-197
Authors:
MERGNY JL
LACROIX L
HAN XG
LEROY JL
HELENE C
Citation: Jl. Mergny et al., INTRAMOLECULAR FOLDING OF PYRIMIDINE OLIGODEOXYNUCLEOTIDES INTO AN I-DNA MOTIF, Journal of the American Chemical Society, 117(35), 1995, pp. 8887-8898
Authors:
ROGERS JT
ANDRIOTAKIS JL
LACROIX L
DURMOWICZ GP
KASSCHAU KD
BRIDGES KR
Citation: Jt. Rogers et al., TRANSLATIONAL ENHANCEMENT OF H-FERRITIN MESSENGER-RNA BY INTERLEUKIN-1-BETA ACTS THROUGH 5' LEADER SEQUENCES DISTINCT FROM THE IRON-RESPONSIVE ELEMENT, Nucleic acids research, 22(13), 1994, pp. 2678-2686
Authors:
LACROIX L
BLAKE GP
COURNOYER D
HUTCHISON JL
PALTIEL O
RYBKA W
SOLYMOSS S
LECLERC JR
Citation: L. Lacroix et al., HIGH-DOSE ETOPOSIDE AND CYCLOPHOSPHAMIDE AS CYTOREDUCTIVE THERAPY IN REFRACTORY RELAPSED LYMPHOMAS AND LEUKEMIAS - AN UPDATE OF 46 PATIENTS, Blood, 82(10), 1993, pp. 10000138-10000138
Authors:
AYOUB JP
CHALK C
LACROIX L
Citation: Jp. Ayoub et al., A UNIQUE INFLAMMATORY POLYNEUROPATHY IN A PATIENT WITH HODGKINS-DISEASE, Blood, 82(10), 1993, pp. 10000558-10000558
Risultati:
1-14
|